Caroline Robert

Caroline Robert, M.D., Ph.D. did her MD training at the Paris V University School of Medicine, France and completed a research fellowship at Harvard, Brigham & Women’s hospital, Boston MA, USA in Cancer Immunology and Immunotherapy. She is presently Head of the Dermatology Service at Gustave Roussy Cancer Campus and co-director of the Melanoma Research Unit at INSERM 981 Paris-Sud University. She is a Professor of Dermatology and responsible for teaching Dermatology and Dermato-Oncology in Paris-Saclay University Medicine School. Her main interests are clinical and translational research on melanoma and non-melanoma skin cancers involving immunotherapy and targeted therapy. She is a national and international coordinator of many clinical trials from phase I to III dedicated to patients with melanoma and other skin cancers. Her research focuses on the involvement of the control of mRNA translation in resistance to cancer therapies. The objectives are the identification of new predictive biomarkers, as well as the development of new therapies to delay therapeutic resistance. She has authored more than 400 articles in peer-reviewed scientific journals. She is a member of the editorial board of Cell and New England Journal of Medicine Evidence.

She is past-President of the Melanoma group of the EORTC (European Organization for the Research and Treatment of Cancer) and is board member of several European and US cooperative groups: EADO (European Association of Onco-Dermatology), ESMO (European Society for Medical Oncology), EADV (European Association of Dermato-Venereology), ASCO (Association of Clinical Oncology) and AACR (American association of Clinical Research).

She has received several awards and prizes including the Estela Medrano Award for the Society for Melanoma Research in 2018 and the ESMO Woman Award in 2020. She was elected as a corresponding member of the French National Academy of Medicine in 2019. She was made a knight of the French Legion of Honor in 2014 and an Officer of the French National Order of Merit in 2021.